Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium
about
sameAs
Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarctionInternational Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapyResistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levelsTwo open states of P2X receptor channelsThe expression level of ecto-NTP diphosphohydrolase1/CD39 modulates exocytotic and ischemic release of neurotransmitters in a cellular model of sympathetic neuronsATPace™: injectable adenosine 5'-triphosphate : Diagnostic and therapeutic indications.Cardiac purinergic signalling in health and diseaseHigh oxygen tension constricts epineurial arterioles of the rat sciatic nerve via reactive oxygen species.New insights in the contribution of voltage-gated Na(v) channels to rat aorta contractionStructure-activity relationship of (N)-Methanocarba phosphonate analogues of 5'-AMP as cardioprotective agents acting through a cardiac P2X receptor.Developmental aspects of cardiac Ca(2+) signaling: interplay between RyR- and IP(3)R-gated Ca(2+) storesCREB modulates calcium signaling in cAMP-induced bone marrow stromal cells (BMSCs).Purinergic regulation of neutrophil chemotaxis.A new function for ATP: activating cardiac sympathetic afferents during myocardial ischemia.P2 receptors: new potential players in atherosclerosisPurinergic signaling is required for fluid shear stress-induced NF-κB translocation in osteoblastsLoss of ectonucleotidases from the coronary vascular bed after ischemia-reperfusion in isolated rat heart.Gene targeting and Calcium handling efficiencies in mouse embryonic stem cell lines.Pharmacological and molecular characterization of functional P2 receptors in rat embryonic cardiomyocytes.Variation in glucose homeostasis traits associated with P2RX7 polymorphisms in mice and humans.Uridine-5'-triphosphate (UTP) reduces infarct size and improves rat heart function after myocardial infarct.Functional contribution of P2Y1 receptors to the control of coronary blood flow.Cardiomyogenesis in the developing heart is regulated by c-kit-positive cardiac stem cells.Involvement of UTP in protection of cardiomyocytes from hypoxic stress.ATP release via anion channels.Interaction between vanilloid receptors and purinergic metabotropic receptors: pain perception and beyond.Phospholipase C and cAMP-dependent positive inotropic effects of ATP in mouse cardiomyocytes via P2Y11-like receptors.In silico characterization of Plasmodium falciparum purinergic receptor: a novel chemotherapeutic target.Cardiomyocyte ATP release through pannexin 1 aids in early fibroblast activationSpatial distribution of maxi-anion channel on cardiomyocytes detected by smart-patch technique.P2 receptors in cardiovascular regulation and diseaseCardiac progenitor cells engineered with Pim-1 (CPCeP) develop cardiac phenotypic electrophysiological properties as they are co-cultured with neonatal myocytes.Ecto-nucleoside triphosphate diphosphohydrolase 7 controls Th17 cell responses through regulation of luminal ATP in the small intestineLncRNA NONRATT021972 involved the pathophysiologic processes mediated by P2X7 receptors in stellate ganglia after myocardial ischemic injuryThe therapeutic effect of 2-cyclohexylthio-AMP in heart failure.P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosisEffects of exogenous nicotinamide adenine dinucleotide (NAD+) in the rat heart are mediated by P2 purine receptors.Sensory-sympathetic coupling in superior cervical ganglia after myocardial ischemic injury facilitates sympathoexcitatory action via P2X7 receptor.Reversal of cardiac myocyte dysfunction as a unique mechanism of rescue by P2X4 receptors in cardiomyopathy.Cell signaling via the P2X(7) nucleotide receptor: linkage to ROS production, gene transcription, and receptor trafficking
P2860
Q24616233-0227FBCC-0103-4EE7-BC45-AC9A4931E1A6Q24629255-0610DAC0-F8E6-479D-9478-204E087674A6Q24816368-1290ABCE-D1AD-476E-A8EF-3F8F7EF209E4Q26851893-927D1D36-84EF-422A-9B3A-DE2B0B1759F8Q28575419-6E855F2E-5F8D-495E-A329-048591C53519Q33160633-EE681D33-77D1-460D-9910-70576937CB7CQ33165093-D62E51E9-A7A1-4DB4-9101-0CB0998D90CEQ33285130-BC28531D-A331-42D4-B7B5-93519EFB9116Q33509015-6D37D232-3281-46B4-981A-7770A7AB77ECQ33894544-6FBC91CF-07B8-4D1D-B2CB-BF0A152EE654Q33917202-F74DA76B-EF53-4C45-9072-64BB207A08A6Q34302065-FAFE77EF-D0B8-4BBE-A46E-94E948464862Q34425713-A108D255-E1B2-445B-AFA3-3D93526AE172Q34426215-13958C53-74F3-49D6-808B-70B649B0AE7EQ34542194-FF8F78A6-B4B0-434E-A700-230748325619Q34629041-8D8D2987-392C-4D7C-B114-6ADEDE27D1BCQ34868955-99F8EAB9-F2FE-43D9-9FC4-97A511D4E45DQ34992302-F95C7E95-2808-43AB-A5FF-9E3188203E3FQ35107188-B3D0F6C4-8F62-4BBF-BDC1-FF94A7B0F761Q35578275-F922942D-B6C2-48CB-B4F5-DE10AA389B2AQ35600506-73A3AE64-1B3B-4994-B1A9-37758C870B52Q35601707-CCBB000D-5E08-401B-9795-CA85B07548D9Q35798731-4F04CCFD-A4B9-4222-A571-78BF07AC870DQ36152106-F0288847-3CBB-4B9B-8BBD-1E33D9920272Q36173784-C291AE4B-64CB-40E9-B238-F5C5EDB6D652Q36224329-0040DFB4-82A2-4771-8F8D-0560377C56E5Q36317194-A2371E49-C456-4B06-AB5B-DB17D3921044Q36396565-F9AFCFAF-94AF-4FDD-A889-524921AF6A5CQ36454202-E9A29D81-8F9B-4DD8-9F20-10E2FBB03908Q36459044-8B2FFC18-D379-4FAB-B218-97CBF8FDE39AQ36464824-6DC43105-CEC4-471A-AD78-19C9F709A23EQ36483220-9EB5597A-92A3-4BCB-9C54-32C83C0FEAFFQ36516823-D63B167D-B343-4C5A-81C2-296C71F32383Q36568412-47508881-01CD-4B2D-9843-9A42E1C71509Q36913394-C43959BF-E9EC-4051-95F8-5499E42AA128Q37008361-3A026469-2BDE-4CBF-BAC9-2B4BC64340C6Q37045432-125AC25D-85FB-4440-9A3D-F5DFDB9AC3B5Q37131969-0CA09BE1-89D4-448E-AB0D-B08957C54B37Q37162591-BF040A43-957B-4303-9FBE-E8AD95000BDAQ37203208-A77A38C3-FF77-4E68-BB98-6A6D4E0A1992
P2860
Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium
@ast
Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium
@en
Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium
@nl
type
label
Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium
@ast
Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium
@en
Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium
@nl
prefLabel
Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium
@ast
Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium
@en
Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium
@nl
P3181
P1476
Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium
@en
P2093
P304
P3181
P356
10.1152/PHYSREV.2001.81.2.767
P407
P577
2001-04-01T00:00:00Z